Popular topics to explore
WOCKPHARMA
stock witnessed a major breakdown after failing to hold its key support at βΉ1411 on Friday, 25 Sept 2025. The decline was triggered by the recent tariff imposed by U.S. President Trump on pharma companies, sparking heavy selling pressure. The stock has now closed below its 200 DEMA, indicating weakness across all time frames. Earlier, on 11 Aug and 2 Sept 2025, the price tested the 200 DEMA and rebounded ~9% and ~12%, respectively. However, the third attempt failed, leading to a decisive close below the crucial average. With the 20 DEMA now slipping below the 50 DEMA, the short- and mid-term trends have turned bearish. The 200 DEMA breakdown further signals a potential long-term trend reversal. Immediate support lies near βΉ1290, with major support at βΉ1110.
π Disclaimer:
This content is for information only and not investment advice. Investments in securities market are subject to market risks. Read all the related documents carefully before investing. Please consult a SEBI-registered advisor before making any investment decisions.#Post-ClosingCommentary#TrendingSectors#WatchOutFor#EquityResearch
530 likesΒ·62 comments

















